Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 28;16(36):4519-25.
doi: 10.3748/wjg.v16.i36.4519.

Recent standardization of treatment strategy for pancreatic neuroendocrine tumors

Masayuki Imamura  1
Affiliations

Recent standardization of treatment strategy for pancreatic neuroendocrine tumors

Masayuki Imamura. World J Gastroenterol. .

Abstract

Recent advances in localization techniques, such as the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy have promoted curative resection surgery for patients with pancreatic neuroendocrine tumors (PNET). For patients with sporadic functioning PNET, curative resection surgery has been established by localization with the SASI test using secretin or calcium. For curative resection of functioning PNET associated with multiple endocrine neoplasia type 1 (MEN 1) which are usually multiple and sometimes numerous, resection surgery of the pancreas and/or the duodenum has to be performed based on localization by the SASI test. As resection surgery of PNET has increased, several important pathological features of PNET have been revealed. For example, in patients with Zollinger-Ellison syndrome (ZES), duodenal gastrinoma has been detected more frequently than pancreatic gastrinoma, and in patients with MEN 1 and ZES, gastrinomas have been located mostly in the duodenum, and pancreatic gastrinoma has been found to co-exist in 13% of patients. Nonfunctioning PNET in patients with MEN 1 becomes metastatic to the liver when it is more than 1 cm in diameter and should be resected after careful observation. The most important prognostic factor in patients with PNET is the development of hepatic metastases. The treatment strategy for hepatic metastases of PNET has not been established and aggressive resection with chemotherapy and trans-arterial chemoembolization have been performed with significant benefit. The usefulness of octreotide treatment and other molecular targeting agents are currently being assessed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schema of the selective arterial secretagogue injection test. Results of the selective arterial secretagogue injection (SASI) test in a patient with Zollinger-Ellison syndrome. In this patient, serum immunoreactive gastrin (IRG) at 40 s after the injection of 30 units of secretin rose only after injection into the gastroduodenal artery. Thus, it was diagnosed that the gastrinoma(s) was located in the upper part of the pancreas and/or the duodenum. Gastr.duod.a: Gastroduodenal artery; Spl.a.: Splenic artery; Superior mesenteric a.: Superior mesenteric artery.
Figure 2
Figure 2
Numerous mucosal gastrinomas in the duodenum. Mucosal tumors with depression (arrows).
Figure 3
Figure 3
A cluster of G cells in hyperplasia of duodenal Brunner’s glands in a patient with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Imamura M, Takahashi K, Adachi H, Minematsu S, Shimada Y, Naito M, Suzuki T, Tobe T, Azuma T. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg. 1987;205:230–239. - PMC - PubMed
    1. Krenning EP, Kwekkeboom DJ, Oei HY, de Jong RJ, Dop FJ, Reubi JC, Lamberts SW. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann N Y Acad Sci. 1994;733:416–424. - PubMed
    1. Soga J. The term "carcinoid" is a misnomer: the evidence based on local invasion. J Exp Clin Cancer Res. 2009;28:15. - PMC - PubMed
    1. Klöppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21:15–31. - PubMed
    1. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS) Neuroendocrinology. 2004;80:394–424. - PubMed

MeSH terms

-